Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

被引:3
|
作者
Hsieh, Meng-Hsuan [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Bair, Ming-Jong [14 ]
Tsai, Pei-Chien [2 ,3 ]
Tseng, Kuo-Chih [32 ]
Lo, Ching-Chu [19 ]
Chen, Chi-Yi [20 ]
Kuo, Hsing-Tao [23 ]
Hung, Chao-Hung [9 ,10 ]
Lai, Hsueh-Chou [18 ]
Peng, Cheng-Yuan [18 ]
Wang, Jing-Houng [21 ]
Chen, Jyh-Jou [33 ]
Lee, Pei-Lun [33 ]
Chien, Rong-Nan [24 ]
Yang, Chi-Chieh [16 ]
Lo, Gin-Ho [11 ,12 ]
Kao, Jia-Horng [25 ,26 ]
Liu, Chun-Jen [25 ,26 ]
Liu, Chen-Hua [25 ,26 ]
Yan, Sheng-Lei [17 ]
Lin, Chun-Yen [24 ]
Su, Wei-Wen [15 ]
Chu, Cheng-Hsin [27 ]
Chen, Chih-Jen [27 ]
Tung, Shui-Yi [9 ,10 ]
Tai, Chi-Ming [11 ,12 ]
Lin, Chih-Wen [11 ,12 ]
Cheng, Pin-Nan [22 ]
Chiu, Yen-Cheng [22 ]
Wang, Chia-Chi [30 ,31 ]
Cheng, Jin-Shiung [13 ]
Tsai, Wei-Lun [13 ]
Lin, Han-Chieh [28 ]
Huang, Yi-Hsiang [28 ,29 ]
Yeh, Ming-Lun [2 ,3 ,4 ,5 ,6 ,7 ]
Huang, Chung-Feng [2 ,3 ,4 ,5 ,6 ,7 ]
Huang, Jee-Fu [2 ,3 ,4 ,5 ,6 ,7 ]
Dai, Chia-Yen [2 ,3 ,4 ,5 ,6 ,7 ]
Yu, Ming-Lung [2 ,3 ,4 ,5 ,6 ,7 ]
Chuang, Wan-Long [2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Dept Occupat & Environm Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Hepatitis Res Ctr, Coll Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan
[7] Kaohsiung Med Univ, Ctr Liquid Biopsy & Cohort Res, Kaohsiung, Taiwan
[8] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan
[9] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan
[10] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
[11] I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan
[12] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan
[13] Kaohsiung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Kaohsiung, Taiwan
[14] Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan
[15] Changhua Christian Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan
[16] Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan
[17] Chang Bing Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan
[18] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan
[19] St Martin Porres Hosp Daya, Dept Internal Med, Daya, Taiwan
[20] Chiayi Christian Hosp, Dept Internal Med, Chiayi, Taiwan
[21] ChiaYi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Chiayi, Taiwan
[22] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med,Coll Med, Tainan, Taiwan
[23] Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan
[24] Chang Gung Mem Hosp, Div Hepatol, Dept Gastroenterol & Hepatol, Linkou Med Ctr, Keelung, Taiwan
[25] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[26] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan
[27] MacKay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan
[28] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
[29] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[30] Buddhist Tzuchi Med Fdn, Div Gastroenterol, Taipei Tzuchi Hosp, Dept Internal Med, New Taipei, Taiwan
[31] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[32] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Gastroenterol, Chiayi, Taiwan
[33] Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Tainan, Taiwan
关键词
chronic kidney disease; end‐ stage renal disease; hepatitis C virus; interferon; VIRUS-INFECTION; GLUCOSE ABNORMALITIES; VIRAL-HEPATITIS; FIBROSIS; OUTCOMES; ASSOCIATION; NATIONWIDE; GENOTYPE; COHORT; AREA;
D O I
10.1111/jgh.15469
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim Chronic hepatitis C virus (HCV) infection is associated with impaired renal function. The aim of this study is to explore the risk of and factors associated with end-stage renal diseases (ESRD) under maintenance dialysis among HCV patients after anti-HCV therapy. Methods A total of 12 696 HCV-infected patients with interferon-based therapy, including 9679 (76.2%) achieving sustained virological response (SVR), were enrolled from 23 hospitals in Taiwan. Results During a mean follow-up period of 5.3 years (67 554 person-years), the annual incidence of 4.1/10 000 person-years, 4.0/10 000 and 4.7/10 000 person-years among SVR patients and non-SVR patients, respectively. History of diabetes and baseline estimated glomerular filtration rate < 60 mL/min/m(2), instead of SVR, were the significant risk factors for developing ESRD with maintenance dialysis after anti-HCV therapy (adjusted hazard ratio 7.75 and 9.78). Conclusion Diabetes and baseline impaired renal function were strongly associated with progression to ESRD with maintenance dialysis among chronic HCV-infected patients after antiviral therapy.
引用
收藏
页码:2247 / 2254
页数:8
相关论文
共 50 条
  • [41] Risk factors of cardiac complications in patients with end-stage renal disease undergoing maintenance peritoneal dialysis
    Tang, Min
    Fan, Jia-Xiang
    Fang, Jian-Guo
    Wang, Hong-Yu
    Sheng, Jing
    Xu, Lei
    Ma, Shao-Jun
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (07) : 2196 - +
  • [42] Impact of sarcopenia on long-term survival after cardiac surgery for end-stage renal disease patients
    Ikushima, Eigo
    Yasutsune, Toru
    Kishigami, Takehiro
    Takigawa, Tomoya
    Jinzai, Yuki
    Kado, Yuichiro
    Nishimura, Yosuke
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (08): : 699 - 705
  • [43] Long-term prognosis in patients with end-stage renal disease after coronary artery bypass grafting
    Pang, Philip Y. K.
    Teow, Christopher K. J.
    Huang, Ming Jie
    Naik, Madhava J.
    Lim, See Lim
    Chao, Victor T. T.
    Tan, Teing Ee
    Chua, Yeow Leng
    Sin, Yoong Kong
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6722 - 6730
  • [44] LONG-TERM METABOLIC CONTROL AFTER TARGETED SURGICAL PARATHYROIDECTOMY IN END-STAGE RENAL DISEASE PATIENTS
    Musa, Farah A. R.
    Clarke, D.
    Gharaibeh, K.
    Tapolyai, M.
    Csongradi
    Pitman, K.
    Fueloep, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 581 - 581
  • [45] Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease
    Kato, Sawako
    Shiels, Paul G.
    McGuinness, Dagmara
    Lindholm, Bengt
    Stenvinkel, Peter
    Nordfors, Louise
    Qureshi, Abdul Rashid
    Yuzawa, Yukio
    Matsuo, Seiichi
    Maruyama, Shoichi
    BLOOD PURIFICATION, 2016, 41 (1-3) : 25 - 33
  • [46] Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience
    Tatar, Bengu
    Kose, Sukran
    Ergun, Nadide Colak
    Turken, Melda
    Onlen, Yusuf
    Yilmaz, Yusuf
    Akhan, Sila
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1470 - 1475
  • [47] BIOPSYCHOSOCIAL ASPECTS OF LONG-TERM SURVIVAL ON END-STAGE RENAL-FAILURE THERAPY
    SHULMAN, R
    PRICE, JDE
    SPINELLI, J
    PSYCHOLOGICAL MEDICINE, 1989, 19 (04) : 945 - 954
  • [48] C HEPATITIS INFECTION AGGRAVATES END-STAGE RENAL DISEASE RISK IN DIABETES PATIENTS
    Hwang, Jyh-Chang
    Jiang, Ming-Yan
    Lu, Yi-Hua
    Weng, Shih-Feng
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [49] Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis
    Kataruka, Manik
    Gupta, Shefali
    Ramchandran, Raja
    Singh, Mini
    Dhiman, Radha Krishan
    Gupta, Kishan Lal
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (04) : 316 - 321
  • [50] Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis
    Scalise, Filippo
    Sole, Andrea
    Singh, Gurbhej
    Sorropago, Antonio
    Sorropago, Giovanni
    Ballabeni, Cinzia
    Maccario, Massimo
    Vettoretti, Simone
    Grassi, Guido
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2020, 38 (05) : 936 - 942